Compare HUT & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HUT | MMSI |
|---|---|---|
| Founded | 2011 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.8B |
| IPO Year | N/A | 1990 |
| Metric | HUT | MMSI |
|---|---|---|
| Price | $45.04 | $86.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | $45.07 | ★ $105.38 |
| AVG Volume (30 Days) | ★ 7.9M | 716.2K |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.89 | ★ 1.95 |
| Revenue | $178,318,000.00 | ★ $1,477,128,000.00 |
| Revenue This Year | $74.79 | $13.38 |
| Revenue Next Year | $116.78 | $6.50 |
| P/E Ratio | ★ $24.02 | $44.38 |
| Revenue Growth | 5.60 | ★ 11.41 |
| 52 Week Low | $10.04 | $78.12 |
| 52 Week High | $57.29 | $111.45 |
| Indicator | HUT | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 55.33 | 53.89 |
| Support Level | $31.67 | $82.70 |
| Resistance Level | $41.06 | $88.57 |
| Average True Range (ATR) | 4.38 | 2.41 |
| MACD | 0.22 | -0.00 |
| Stochastic Oscillator | 77.59 | 68.75 |
Hut 8 Corp is an energy infrastructure operator and Bitcoin miner with self-mining, hosting, managed services, and traditional data center operations across North America. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.